1367 Development of an inactivated vaccine candidate for SARS-CoV-2.
https://science.sciencemag.org/content/369/6499/77
1366 SARS-CoV-2 infects enterocytes in human small intestinal organoids.
https://science.sciencemag.org/content/369/6499/50
1365 Identifying airborne transmission as the dominant route for the spread of COVID-19.
https://www.pnas.org/content/117/26/14857
1364 Aerodynamic analysis of SARS-CoV-2 RNA in two hospitals in Wuhan indicates that SARS-CoV-2 may have the potential to be transmitted through aerosols, although the infectivity of the virus RNA was not established in this study.
https://www.nature.com/articles/s41586-020-2271-3
1363 Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions.
https://www.pnas.org/content/117/25/13967
1362 Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
https://science.sciencemag.org/content/368/6497/1331.editor-summary
1361 Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease.
https://stm.sciencemag.org/content/12/548/eaay5691
1360 An engraved surface induces weak adherence and high proliferation of nonadherent cells and microorganisms during culture.
https://www.future-science.com/doi/10.2144/btn-2020-0022
1359 Rapid, sensitive, specific, and scalable object provenance with barcoded microbial spores.
https://science.sciencemag.org/content/368/6495/1135
1358 An amphipathic peptide targeting the gp41 cytoplasmic tail kills HIV-1 virions and infected cells.
https://stm.sciencemag.org/content/12/546/eaaz2254
|